What is the global market size of Synthetic Biology Market?

Global Synthetic Biology Market size was valued at USD 11 billion in 2021 and is poised to grow from USD 13.09 billion in 2022 to USD 55.37 billion by 2030, growing at a CAGR of 18.97% in the forecast period (2023-2030).

Who are the key vendors in the Global Synthetic Biology Market?

Because of the existence of big, regional, and global competitors in the industry, the synthetic biology market is fragmented and competitive. Small start-ups concentrating on specialized technologies, as well as huge corporations with a diverse portfolio of services and resources, are among the industry players. Vendors compete on the basis of technology, brand identity, and product portfolio. Companies are employing a variety of methodologies since synthetic biology encompasses a wide range of tools such as DNA sequencing and genome engineering. Some market participants concentrate on a single technology or sector, such as biofuels, whilst others concentrate on a specific technique, such as genome engineering, which has various uses. Collaborations and partnerships are two additional significant techniques employed by suppliers. 'Thermo Fisher Scientific Inc.', 'Ginkgo Bioworks', 'Twist Bioscience Corporation', 'Codexis Inc.', 'Intrexon Corporation', 'Synthetic Genomics Inc.', 'Amyris Inc.', 'Zymergen Inc.', 'GenScript Biotech Corporation', 'Evolva Holding SA', 'DSM NV', 'ATUM', 'Editas Medicine', 'Genomatica Inc.', 'Global Bioenergies SA', 'BioAmber Inc.', 'Gevo Inc.', 'Synthace Limited', 'Arzeda Corporation', 'Inscripta Inc', 'In January 2022, Ribbon Biolabs, a DNA synthesis company, has raised ~USD 19.6 million in series A funding. With this fund, the company enabled commercial-scale production facilities and the expansion of DNA synthesis technology in the United States.', 'In February 2021, Merck partnered with BioNTech (Germany) to supply lipids for the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).', 'In January 2021, Novozymes launched Frontia GlutenEx. It would assist wheat processors in increasing gluten protein recovery while also reducing energy use.', 'In January 2021, Merck acquired AmpTec (Germany). The firm expanded its product range by developing and manufacturing mRNA for use in vaccinations, therapies, and diagnostics as a result of this purchase.'

What is the key driver of Global Synthetic Biology Market?

Due to lengthy research and regulatory procedures, the R&D business has always been capital-intensive. Governments see R&D as a critical investment for any country's prosperity, international competitiveness, and public benefit. As a result, R&D investment and funding have steadily increased throughout the years. From 2018 to 2019, R&D investment in the life sciences business increased by 22%. Pharmaceutical and biotechnology businesses spend extensively in research to produce game-changing compounds to meet the rising requirements of the healthcare sector and tackle emerging ailments. The worldwide pharmaceutical R&D sector contributes for over 80% of total R&D investment in the life sciences industry.

What is the key market trend for Global Synthetic Biology Market?

The medical applications segment is expected to grow at a fastest CAGR. The availability of large corporate and governmental financing for the development of novel cures, as well as extensive research on new and better treatments, is the key driver of the medical applications segment's growth.

Which region accounted for the largest share in Global Synthetic Biology Market?

The synthetic biology market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the largest proportion of the synthetic biology market in 2020, followed by Europe and Asia Pacific. The growth in the number of well-established synthetic biology firms and research institutes in the United States and Canada is linked to the high proportion of the North American market. Other significant causes include the high number of current research investigations and the global expansion of the healthcare sector.

Top Synthetic Biology Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Synthetic Biology Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Synthetic Biology industry players.

Synthetic Biology Market Competitive Landscape

Because of the existence of big, regional, and global competitors in the industry, the synthetic biology market is fragmented and competitive. Small start-ups concentrating on specialized technologies, as well as huge corporations with a diverse portfolio of services and resources, are among the industry players. Vendors compete on the basis of technology, brand identity, and product portfolio. Companies are employing a variety of methodologies since synthetic biology encompasses a wide range of tools such as DNA sequencing and genome engineering. Some market participants concentrate on a single technology or sector, such as biofuels, whilst others concentrate on a specific technique, such as genome engineering, which has various uses. Collaborations and partnerships are two additional significant techniques employed by suppliers.

Synthetic Biology Market Top Players Company Profiles

Thermo Fisher Scientific Inc.
Ginkgo Bioworks
Twist Bioscience Corporation
Codexis Inc.
Intrexon Corporation
Synthetic Genomics Inc.
Amyris Inc.
Zymergen Inc.
GenScript Biotech Corporation
Evolva Holding SA
DSM NV
ATUM
Editas Medicine
Genomatica Inc.
Global Bioenergies SA
BioAmber Inc.
Gevo Inc.
Synthace Limited
Arzeda Corporation
Inscripta Inc

Synthetic Biology Market Recent Developments

In January 2022, Ribbon Biolabs, a DNA synthesis company, has raised ~USD 19.6 million in series A funding. With this fund, the company enabled commercial-scale production facilities and the expansion of DNA synthesis technology in the United States.
In February 2021, Merck partnered with BioNTech (Germany) to supply lipids for the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).
In January 2021, Novozymes launched Frontia GlutenEx. It would assist wheat processors in increasing gluten protein recovery while also reducing energy use.
In January 2021, Merck acquired AmpTec (Germany). The firm expanded its product range by developing and manufacturing mRNA for use in vaccinations, therapies, and diagnostics as a result of this purchase.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Synthetic Biology Market size was valued at USD 17.8 Billion in 2024 and is poised to grow from USD 22.34 Billion in 2025 to USD 137.47 Billion by 2033, growing at a CAGR of 25.5% during the forecast period (2026–2033).

The synthetic biology market providers need to focus on maximizing their business scope by reaching into new markets and developing synthetic biology for different industrial and personal uses. Raising new capital to fund their R&D and business expansion efforts will be essential for new synthetic biology companies going forward. The development of custom robots for specific applications across different industry verticals will also help companies expand their sales potential in the future. 'Genentech Inc. (U.S.) ', 'Sorenson Genomics, LLC (U.S.) ', 'Abbott Molecular (U.S.) ', 'Bayer Diagnostics (U.S.) ', 'Genomic Health (U.S.) ', 'Thermo Fisher Scientific Inc. (US) ', 'Merck KGaA (Germany) ', 'Agilent Technologies (US) ', 'Novozymes (Denmark) ', 'Ginkgo Bioworks (US) ', 'Amyris (US) ', 'Precigen, Inc. (US) ', 'GenScript (China) ', 'Twist Bioscience (US) ', 'Synthetic Genomics (US) ', 'Codexis, Inc. (US) ', 'Synthego (US) ', 'Creative Enzymes (US) ', 'Eurofins Scientific (Luxembourg) ', 'Bota Biosciences Inc. (China) ', 'Creative Biogene (US) ', 'Enbiotix, Inc. (US) ', 'Illumina, Inc. (US) ', 'New England Biolabs (US) ', 'Pareto Bio, Inc. (US) '

Synthetic biology is improving the emergence of novel therapies, diagnostics, and vaccines, impacting the surging use in healthcare and pharmaceutical sectors. Furthermore, the said technology is used in the development of genetically tailored crops with improved resistance to diseases and pests, which aids agriculture productivity and food security. These factors are impressively helping the growth of the synthetic biology market.

Engineered gene’s expression is dictated by complex & dynamic epigenetics and DNA sequence. This over-activates synthetic constructs, resulting in inconsistent outcomes. Owing to this feature, the newbies in the market are bringing innovations in epigenetics technologies to navigate and handle these intricacies.

Geographically, the synthetic biology market is leading in North America owing to several factors like robust research and development architecture. Mainly, Canada and the United States holds a strong infrastructure for research and development. This comprises top-class universities, research institutes, and biotech companies that fuel inventions and advances in the domain of synthetic biology. Moreover, growing funding and heavy investments in synthetic biology and biotechnology from both public and private sectors aid better research and development of technologies in the region. The leading vendors operating in North America include Thermo Fisher Scientific, Agilent Technologies, Ginkgo Bioworks, and Amyris, Inc. among others.

Top Synthetic Biology Companies

Synthetic Biology Market Competitive Landscape

FAQs

What is the global market size of Synthetic Biology Market?

Who are the key vendors in the Synthetic Biology Market?

What is the key driver of Synthetic Biology Market?

What is the key market trend for Synthetic Biology Market?

Which region accounted for the largest share in Synthetic Biology Market?

Request Free Customization